MedPath

JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMET L.L.C.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy

Phase 3
Completed
Conditions
Epilepsy
Epilepsies, Partial
Seizures
First Posted Date
2005-10-12
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
90
Registration Number
NCT00236743

A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization

Phase 3
Completed
Conditions
Nosocomial Pneumonia
First Posted Date
2005-10-12
Last Posted Date
2011-06-10
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
438
Registration Number
NCT00236834

A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Treating Tremor of Unknown Cause.

Phase 3
Completed
Conditions
Essential Tremor
First Posted Date
2005-10-12
Last Posted Date
2011-06-10
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
223
Registration Number
NCT00236496

A Comparison of the Safety and Efficacy of Two Different Regimens of Levofloxacin in the Treatment of Acute Bacterial Sinusitis(Sinus Infection) in Adults.

Phase 3
Completed
Conditions
Sinusitis
First Posted Date
2005-10-12
Last Posted Date
2011-06-10
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
784
Registration Number
NCT00236522

A Study Comparing Safety and Efficacy of Levofloxacin and Metronidazole Versus Piperacillin/Tazobactam in Treating Complicated Appendicitis

Phase 4
Terminated
Conditions
Appendicitis
First Posted Date
2005-10-12
Last Posted Date
2011-06-10
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
139
Registration Number
NCT00236912

A Study to Compare the Safety and Effectiveness of 2 Doses of Levofloxacin Given for Different Time Periods in Patients With Pneumonia

Phase 3
Completed
Conditions
Pneumonia
First Posted Date
2005-10-12
Last Posted Date
2011-06-10
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
530
Registration Number
NCT00236821

A Study to Evaluate the Safety and Effectiveness of Levofloxacin Compared With Ciprofloxacin in Patients With Chronic Bacterial Prostatitis

Phase 3
Completed
Conditions
Prostatitis
First Posted Date
2005-10-12
Last Posted Date
2011-06-10
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
383
Registration Number
NCT00236808

A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days.

Phase 3
Completed
Conditions
Maxillary Sinusitis
First Posted Date
2005-10-12
Last Posted Date
2011-06-10
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
18
Registration Number
NCT00236652

Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT

Phase 2
Terminated
Conditions
Anemia
Rheumatoid Arthritis
First Posted Date
2005-10-12
Last Posted Date
2011-06-10
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
29
Registration Number
NCT00236678

PROCRIT and Short-Term Outcomes in Orthopedic Surgery

Phase 2
Terminated
Conditions
Anemia
Surgery, Arthroscopy
First Posted Date
2005-10-12
Last Posted Date
2011-06-10
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
6
Registration Number
NCT00236405
© Copyright 2025. All Rights Reserved by MedPath